Risk of tuberculosis during infliximab therapy for inflammatory bowel disease, rheumatoid arthritis, and spondyloarthropathy: A meta-analysis.

Wang, Qiang; Wen, Zhenzhen; Cao, Qian

Wang, Qiang; Wen, Zhenzhen; Cao, Qian.

Afiliação

Wang Q; Department of Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China.
Wen Z; Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.
Cao Q; Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310016, P.R. China.

Exp Ther Med ; 12(3): 1693-1704, 2016 Sep.

Article em En | MEDLINE | ID: mdl-27588089

Palavras-chave

inflammatory bowel disease; infliximab; meta-analysis; rheumatoid arthritis; spondyloarthropathy; tuberculosis infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Exp Ther Med Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google